This activity is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Genentech, a member of the Roche Group.
NPs and PAs
Identify the signs and symptoms of IPF to make an accurate diagnosis and referral earlier in the course of disease
Devise a treatment plan that incorporates current treatment guidelines and therapies as well as management of comorbidities and risk factors
Apply effective communication and shared decision-making skills during patient visits
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Kershaw: consulting fees: Boehringer Ingelheim.
Ms Young has no relevant financial relationships to disclose.
None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.
Participants wishing to earn CE/CME credit must:
The estimated time to complete this activity is 1.00 hour.
Release date: November 23, 2021
Expiration date: November 22, 2022
Interactive video lecture
The opinions or views expressed in this continuing education activity are those of the faculty and do not necessarily reflect the opinions of Practicing Clinicians Exchange or any educational supporter.
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
Nursing contact hours: 1.00, which includes 1.00 hours of pharmacology credit
AAPA Credit Designation
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until November 22, 2022. PAs should only claim credit commensurate with the extent of their participation.
PA course advisor: John Hardisty, MS, MSPAS, PA-C, Colorado Springs Pulmonary Consultants, Colorado Springs, Colorado
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This program has been made available online.